Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative 177Lu-PSMA radioligand therapy before prostatectomy in node-positive hormone-sensitive prostate cancer
NL-OMON29417Phase 2Not yet recruiting
- Sponsor
- To be determined
- Start
- Jan 2021
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by To be determined. Primary endpoint: Histopathological response in resected specimens. Planned start Jan 2021; status: not yet recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON29417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29417.